文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

乌干达高危脓毒症免疫表型以多形核髓源性抑制细胞异质性扩增为特征

HETEROGENEOUS EXPANSION OF POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS DISTINGUISHES HIGH-RISK SEPSIS IMMUNOPHENOTYPES IN UGANDA.
PubMed 文献 · Shock · 2024-05-30
一句话结论乌干达成人脓毒症前瞻性队列中,CD16−PD-L1dim多形核髓源性抑制细胞扩增与CD16brightPD-L1bright亚群减少及CD4+T细胞、树突状细胞、CD56−CD16brightNK细胞耗竭独立于HIV感染与60天死亡风险显著相关。

在乌干达43例疑似脓毒症住院成人前瞻性队列中(中位年龄46岁,IQR 36-59;24例[55.8%]合并HIV感染;16例[37.2%]60天死亡),结合高维流式细胞术、无监督机器学习与人工设门定义与外周免疫表型与60天死亡风险的关联。死亡患者显示多形核髓源性抑制细胞异质性扩增:CD16−PD-L1dim亚群丰度增加、CD16brightPD-L1bright亚群丰度减少均与死亡显著相关;前者与死亡风险的关联贯穿病程,后者在起病早期更明显。独立于HIV合并感染,CD4+T细胞、树突状细胞和CD56−CD16brightNK细胞减少及未成熟CD56+CD16−CD11c+NK细胞扩增与死亡风险显著相关;表达抑制性检查点蛋白(PD-1、CTLA-4、LAG-3)的T细胞丰度在死亡与存活患者间相似。作者认为这是首个在撒哈拉以南非洲成人脓毒症中定义高危免疫表型的研究,提示髓源性抑制细胞扩增的临床重要性与复杂性,并支持PD-L1髓系检查点在急性危重症中可能具有宿主保护作用的新兴数据。

要点

  • 乌干达成人疑似脓毒症前瞻性队列(N=43)中,60天死亡16例(37.2%),死亡患者CD16−PD-L1dim多形核髓源性抑制细胞丰度增加与死亡显著相关。
  • 死亡患者CD16brightPD-L1bright多形核髓源性抑制细胞丰度减少与死亡显著相关,该关联在起病早期更明显。
  • 独立于HIV合并感染,CD4+T细胞、树突状细胞和CD56−CD16brightNK细胞减少与死亡风险显著相关。
  • 独立于HIV合并感染,未成熟CD56+CD16−CD11c+NK细胞扩增与死亡风险显著相关。
  • 表达PD-1、CTLA-4、LAG-3的T细胞丰度在死亡与存活患者间相似。

适用人群与场景

  • 乌干达住院成人疑似脓毒症患者,前瞻性队列N=43,中位年龄46岁(IQR 36-59),24例(55.8%)合并HIV感染。

研究设计与关键结果

  • 前瞻性队列N=43,16例(37.2%)60天死亡;采用高维流式细胞术、无监督机器学习与人工设门定义与外周免疫表型与60天死亡风险的关联。
  • 死亡患者显示多形核髓源性抑制细胞异质性扩增:CD16−PD-L1dim亚群丰度增加、CD16brightPD-L1bright亚群丰度减少,均与死亡显著相关。
  • CD16−PD-L1dim细胞丰度与死亡风险的差异贯穿病程,CD16brightPD-L1bright亚群的差异在起病早期更明显。
  • 独立于HIV合并感染,CD4+T细胞、树突状细胞和CD56−CD16brightNK细胞减少与死亡风险显著相关。
  • 独立于HIV合并感染,未成熟CD56+CD16−CD11c+NK细胞扩增与死亡风险显著相关。
  • 表达抑制性检查点蛋白PD-1、CTLA-4、LAG-3的T细胞丰度在死亡与存活患者间相似。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这是首个在撒哈拉以南非洲成人脓毒症中定义高危免疫表型的研究,该地区免疫学特征独特、需要基于生物学信息的治疗策略。
  • 作者认为,研究结果突显脓毒症期间髓源性抑制细胞扩增的临床重要性与复杂性,并支持PD-L1髓系检查点在急性危重症中可能具有宿主保护作用的新兴数据。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Understanding of immune cell phenotypes associated with inflammatory and immunosuppressive host responses in sepsis is imprecise, particularly in low- and middle-income countries, where the global sepsis burden is concentrated. In these settings, elucidation of clinically relevant immunophenotypes is necessary to determine the relevance of emerging therapeutics and refine mechanistic investigations of sepsis immunopathology. Methods: In a prospective cohort of adults hospitalized with suspected sepsis in Uganda (N = 43; median age 46 years [IQR 36-59], 24 [55.8%] living with HIV, 16 [37.2%] deceased at 60 days), we combined high-dimensional flow cytometry with unsupervised machine learning and manual gating to define peripheral immunophenotypes associated with increased risk of 60-day mortality. Results: Patients who died showed heterogeneous expansion of polymorphonuclear myeloid-derived suppressor cells, with increased and decreased abundance of CD16 - PD-L1 dim and CD16 bright PD-L1 bright subsets, respectively, significantly associated with mortality. While differences between CD16 - PD-L1 dim cell abundance and mortality risk appeared consistent throughout the course of illness, those for the CD16 bright PD-L1 bright subset were more pronounced early after illness onset. Independent of HIV co-infection, depletion of CD4 + T cells, dendritic cells, and CD56 - CD16 bright NK cells were significantly associated with mortality risk, as was expansion of immature, CD56 + CD16 - CD11c + NK cells. Abundance of T cells expressing inhibitory checkpoint proteins (PD-1, CTLA-4, LAG-3) was similar between patients who died versus those who survived. Conclusions: This is the first study to define high-risk immunophenotypes among adults with sepsis in sub-Saharan Africa, an immunologically distinct region where biologically informed treatment strategies are needed. More broadly, our findings highlight the clinical importance and complexity of myeloid derived suppressor cell expansion during sepsis and support emerging data that suggest a host-protective role for PD-L1 myeloid checkpoints in acute critical illness.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Cummings MJ, Guichard V, Owor N, et al. HETEROGENEOUS EXPANSION OF POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS DISTINGUISHES HIGH-RISK SEPSIS IMMUNOPHENOTYPES IN UGANDA. Shock. 2024. PMID: 39012778. doi:10.1097/SHK.0000000000002403

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。